Moderna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement under stricte...

Moderna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...

Children in the United States can now take the vaccine against the Covid-19. While a lot of parents are still undecided, some parents are c...

The Food and Drug Administration's action follows its advisory panel's unanimous recommendation for the shots from Moderna and Pfizer. That...

The FDA cautioned that estimates of the efficacy of Moderna's two-dose pediatric vaccine were based on relatively few cases of COVID-19. Th...

The news comes after months of anxious waiting by parents desperate to vaccinate their babies, toddlers and preschoolers, especially as COV...

The Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was granted after Moderna's vaccine, known as Spikevax, me...

Moderna's COVID-19 vaccine works in babies, toddlers and preschoolers the company announced -- and if regulators agree it could mean a chan...

In a press release, the company said its request for approval for all adults was made "to provide flexibility" to the Centers for Disease C...

The latest action simplifies what until now has been a confusing list of who's eligible, allowing anyone 18 or older to choose either compa...

Moderna Inc said on Monday that its COVID-19 vaccine generated an immune response and was generally well-tolerated in children aged six to ...

That compares favorably to data released by rivals Pfizer Inc and BioNTech SE last week in which they suggested their vaccine's efficacy wa...

Moderna's vaccine was given the green light for use in anyone 18 and over across the 27-nation European Union in January. It has also been ...

With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest to end the pandemic. But earlier...

The Moderna vaccine is currently cleared for people 18 and older.

The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the U.S. Some 30,000 volunteers are needed to prove if this...

The study, published in the New England Journal of Medicine, offers a more complete picture of the vaccine's safety in older adults, a grou...